About Aci Pharma Private Limited
Data last updated:
Aci Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 March 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC119266. Its GSTIN is 07AAECA1713F1Z8 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kartik Sahay and Bharti Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Upper Ground Floor Plot No 23 Khasra No – 17/12/21/1, Pochanpur Extn A Block Gali No 2 New Village Pochanpur, Delhi, India – 110077.
As per the financials filed for FY 2024, the company reported a revenue of ₹64,244, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹1.34 Lakh (net margin -208.9%) and EBITDA of -₹1.1 Lakh (EBITDA margin -171.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 56% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acipharm.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUpper Ground Floor Plot No 23 Khasra No – 17/12/21/1, Pochanpur Extn A Block Gali No 2 New Village Pochanpur, Delhi, India – 110077
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aci Pharma Private Limited
The main business activity of Aci Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Aci Pharma Private Limited
Aci Pharma Private Limited is audited by K K BARANWAL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K K BARANWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aci Pharma Private Limited
Aci Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartik Sahay | Director | 22 Nov 2004 | 21 Years 10 Months | Current |
| Bharti Sahay | Director | 01 Apr 2008 | 18 Years 6 Months | Current |
| Priti Chetan | Additional Director | 17 Sep 2021 | 5 Years 0 Months | Current |
Financials of Aci Pharma Private Limited FY 2025 filings available
Aci Pharma Private Limited reported revenue of ₹64,244 (down 94.00% YoY) for FY 2024.
Growth of Aci Pharma Private Limited
| Metric | 1-year growth | 3-year compounded (CAGR) | 5-year compounded (CAGR) |
|---|---|---|---|
| Revenue | ▼ 94% | ▲ 23% | ▼ 56% |
Revenue has declined at a compounded annual rate (CAGR) of 56% over five years, including a 94% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aci Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.34 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aci Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -171.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -208.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aci Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aci Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aci Pharma Private Limited
Aci Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aci Pharma Private Limited
Employment history and EPFO contributions of people linked to Aci Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aci Pharma Private Limited
Aci Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECA1713F1Z8 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aci Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aci Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aci Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aci Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aci Pharma Private Limited
Frequently Asked Questions about Aci Pharma Private Limited
Aci Pharma is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 March 2003 (23+ years old) and is registered under CIN U24239DL2003PTC119266.
Aci Pharma reported revenue of ₹64,244 for FY 2024 (down 94.00% YoY).
Aci Pharma has 3 current directors:
- Kartik Sahay - Director
- Bharti Sahay - Director
- Priti Chetan - Additional Director
Aci Pharma reported a net loss of ₹1.34 Lakh (net margin -208.9%) and EBITDA of -₹1.1 Lakh (EBITDA margin -171.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aci Pharma is 23% over three years and -56% over five years. In the latest year (FY 2024) revenue fell 94%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aci Pharma is 07AAECA1713F1Z8, registered in Delhi.
The CIN (Corporate Identification Number) of Aci Pharma is U24239DL2003PTC119266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aci Pharma was incorporated on 05 March 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Aci Pharma can be reached through the website acipharm.com. Its registered office is in New, Delhi, India.